<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01173042</url>
  </required_header>
  <id_info>
    <org_study_id>PKE105</org_study_id>
    <nct_id>NCT01173042</nct_id>
  </id_info>
  <brief_title>Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides</brief_title>
  <acronym>PKEPEANUT</acronym>
  <official_title>Pilot Study of the Effect of Peanut Consumption on Postprandial Inflammatory Status, Glucose and Triglycerides</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Peanut Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Penn State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study will investigate the effects of acute peanut consumption on markers of
      inflammation, triglycerides and glucose. The hypothesis is that a high glucose/SFA meal will
      increase postprandial production of the inflammatory marker, C-reactive protein (CRP), and
      that the addition of peanuts to the control meal will reduce the production of CRP, as well
      as triglycerides and glucose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous research has demonstrated that a single meal high in saturated fatty acids (SFA) and
      glucose can induce increases in IL-6, TNF-Î± and CRP in abdominally obese and diabetic
      subjects. As over two-thirds of the U.S. population is overweight or obese, it is important
      to identify foods that can attenuate postprandial increases in lipids, glucose and
      inflammation in this population. Therefore, the purpose of the pilot study is to determine
      whether a high SFA / high glucose control meal will induce an acute inflammatory response in
      overweight individuals, and whether the addition of peanuts to this meal will ameliorate this
      response. To ensure that these effects are due to peanuts, and not to the increase in total
      fat, we will compare this response to another test meal that includes an oil blend with a
      similar fatty acid composition to peanuts.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum C-reactive protein</measure>
    <time_frame>0min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum C-reactive protein</measure>
    <time_frame>60 min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum C-reactive protein</measure>
    <time_frame>120 min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum C-reactive protein</measure>
    <time_frame>240 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Glucose</measure>
    <time_frame>0 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Insulin</measure>
    <time_frame>0 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Triglycerides</measure>
    <time_frame>0 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Glucose</measure>
    <time_frame>60 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Glucose</measure>
    <time_frame>120 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Glucose</measure>
    <time_frame>240 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Insulin</measure>
    <time_frame>60 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Insulin</measure>
    <time_frame>120 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Insulin</measure>
    <time_frame>240 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Triglycerides</measure>
    <time_frame>60 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Triglycerides</measure>
    <time_frame>120 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Triglycerides</measure>
    <time_frame>240 min</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Shake containing heavy whipping cream, glucose and chocolate syrup</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peanut</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Shake containing control (whipping cream, glucose and chocolate syrup) + 3oz of peanuts</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oil blend</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Shake containing control (heavy whipping cream, glucose and chocolate syrup) + oil blend (equivalent to fatty acids provided in 3oz peanuts)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Peanuts</intervention_name>
    <description>Shake containing 3.0oz of peanuts (including skin) + control (heavy whipping cream, glucose and chocolate syrup)</description>
    <arm_group_label>Peanut</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucose and whipping cream</intervention_name>
    <description>An oral liquid glucose (75g) and fat (high saturated fat from 60g heavy whipping cream) load. Chocolate syrup is added for flavor.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oil Blend</intervention_name>
    <description>Shake containing an oil blend (sunflower, sesame, olive and palm oils) + control (heavy whipping cream, glucose and chocolate syrup). The amount of oil added to the control will provide an equivalent amount of fat to that provided in 3 oz (85g) of peanuts</description>
    <arm_group_label>Oil blend</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt;28

          -  LDL_C below 130 mg/dl

          -  TG below 350 mg/dl

          -  Blood pressure within normal ranges (below 140/90 mmHg)

        Exclusion Criteria:

          -  Smoking

          -  Allergies to peanuts or dairy products

          -  Known intolerance for high fat meals

          -  History of CVD, kidney disease, diabetes or inflammatory disease

          -  Use of non-steroidal anti-inflammatories or immunosuppressants

          -  Conditions requiring the use of steroids

          -  Use of medication or supplements for elevated lipids, blood pressure or glucose
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alison M Hill, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn State University, Department of Nutritiontal Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Penny M. Kris-Etherton, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn State University, Department of Nutritional Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Li Wang</last_name>
    <role>Study Director</role>
    <affiliation>Penn State University, Department of Nutritional Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn State University</name>
      <address>
        <city>University Park</city>
        <state>Pennsylvania</state>
        <zip>16802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.das.psu.edu/pmke</url>
  </link>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2010</study_first_submitted>
  <study_first_submitted_qc>July 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2010</study_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Penn State University</investigator_affiliation>
    <investigator_full_name>Penny Kris-Etherton</investigator_full_name>
    <investigator_title>Distinguished Professor of Nutrition</investigator_title>
  </responsible_party>
  <keyword>Overweight</keyword>
  <keyword>Obese</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

